株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の連続式血糖値モニタリング(CGM)市場の将来動向

Global Continuous Glucose Monitoring Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 317278
出版日 ページ情報 英文 61 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の連続式血糖値モニタリング(CGM)市場の将来動向 Global Continuous Glucose Monitoring Market 2014-2018
出版日: 2014年10月22日 ページ情報: 英文 61 Pages
概要

連続式血糖値モニタリング(CGM)とは、糖尿病患者の血糖値の水準を一定の間隔で計測することを指します。連続式血糖値モニタリング装置とは、血糖値(グルコース)の管理を目的に、フィンガースティック内部の血糖値レベルの動向を計測するためのシステムです。主な構成部品には、皮下に配置されて組織液の中の血糖値レベルを計測するグルコースセンサーや、計測した血糖値レベルの情報をレシーバー(受信機)およびディスプレイに無線送信するトランスミッター(送信機)などがあります。また、HbA1Cやフルクトサミンのレベルに関する情報も計測・送信します。世界の連続式血糖値モニタリング市場の2013〜2018年の年平均成長率(CAGR)は14.74%に達する見通しです。

当レポートでは、全世界の持続的グルコース測定(CGM)市場について分析し、市場の概要や構造、市場規模の動向(今後5年間の予測値)、製品別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブ・サマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第7章 製品別の市場分析

  • トランスミッター・レシーバー市場
  • グルコースセンサー市場
  • インスリンポンプ市場

第8章 地域別の分析

  • 南北アメリカ市場
  • 欧州・中東・アフリカ(EMEA)地域市場
  • アジア太平洋地域市場

第9章 購入基準

第10章 市場の成長促進要因

第11章 促進要因とその影響力

第12章 市場の課題

第13章 促進要因・課題の影響力

第14章 市場の傾向

第15章 市場動向とその影響

第16章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
    • 企業合併・買収(M&A)
  • 市場シェア分析
  • その他の著名なベンダー
    • 製品ポートフォリオの一覧

第17章 主要ベンダーの分析

  • Abbott Laboratories
    • 主要データ
    • 事業概要
    • 部門別の市場収益額(最新値)
    • 部門別の市場収益額(前年度との比較)
    • 地域別の市場収益額
    • 事業戦略
    • 近年の動向
    • SWOT分析
  • Dexcom
  • Medtronic

第18章 その他の関連分析

図表一覧

目次
Product Code: IRTNTR4391

About Continuous Glucose Monitoring

Continuous glucose monitoring is the measurement of glucose levels at regular intervals from a diabetic patient. Continuous glucose monitoring systems allow to gain insight into the trends of glucose levels between fingersticks, resulting in improved glucose control. Continuous glucose monitoring system comprises of a glucose sensor that is placed subcutaneously to provide the reading of glucose levels in tissue fluid. A transmitter sends information about the glucose levels using radio waves from the sensor to a receiver display. Continuous glucose monitoring system also offers additional information about HbA1C levels and fructosamine levels.

TechNavio's analysts forecast the Global Continuous Glucose Monitoring market to grow at a CAGR of 14.74 percent over the period 2013-2018.

Covered in this Report

The report covers the present scenario and the growth prospects of the Global Continuous Glucose Monitoring market for the period 2014-2018. In terms of component, the Global Continuous Glucose Monitoring market is divided into three segments: Transmitters and Receivers, Glucose Sensors, and Insulin Pumps.

TechNavio's report, the Global Continuous Glucose Monitoring Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Continuous Glucose Monitoring market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Dexcom
  • Medtronic

Other Prominent Vendors

  • Animas
  • Bayer
  • GlySens
  • Insulet
  • Senseonics

Market Driver

  • Growing Number of Diabetic Patients
  • For a full, detailed list, view our report

Market Challenge

  • Presence of Alternative Methods
  • For a full, detailed list, view our report

Market Trend

  • Emerging Artificial Pancreas Technology
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Product

  • 07.1. Global Transmitters and Receivers Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Glucose Sensors Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Insulin Pumps Market
    • 07.3.1. Market Size and Forecast

08. Geographical Segmentation

  • 08.1. Continuous Glucose Monitoring Market in the Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. Continuous Glucose Monitoring Market in the EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. Continuous Glucose Monitoring Market in the APAC Region
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Vendor Analysis 2013
  • 16.3. Other Prominent Vendors
    • 16.3.1. Product Portfolio Matrix

17. Key Vendor Analysis

  • 17.1. Abbott Laboratories
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation by Revenue
    • 17.1.4. Business Segmentation by Revenue 2011 and 2012
    • 17.1.5. Geographical Segmentation by Revenue
    • 17.1.6. Business Strategy
    • 17.1.7. Key Information
    • 17.1.8. SWOT Analysis
  • 17.2. Dexcom
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Product Segmentation by Revenue 2013
    • 17.2.4. Product Segmentation by Revenue 2012 and 2013
    • 17.2.5. Business Strategy
    • 17.2.6. Recent Developments
    • 17.2.7. SWOT Analysis
  • 17.3. Medtronic
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation by Revenue 2013
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Geographical Segmentation by Revenue 2013
    • 17.3.6. Business Strategy
    • 17.3.7. Recent Developments
    • 17.3.8. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Continuous Glucose Monitoring Market 2013-2018 (US$ million)
  • Exhibit 3: Global Continuous Glucose Monitoring Market Segmentation by Devices
  • Exhibit 4: Global Continuous Glucose Monitoring Market Segmentation by Product 2013
  • Exhibit 5: Global Transmitters and Receivers Market 2013-2018 (US$ million)
  • Exhibit 6: Global Glucose Sensors Market 2013-2018 (US$ million)
  • Exhibit 7: Global Insulin Pumps Market 2013-2018 (US$ million)
  • Exhibit 8: Global Continuous Glucose Monitoring Market by Product 2013-2018
  • Exhibit 9: Global Continuous Glucose Monitoring Market by Geographical Segmentation 2013
  • Exhibit 10: Continuous Glucose Monitoring Market in the Americas 2013-2018 (US$ million)
  • Exhibit 11: Continuous Glucose Monitoring Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 12: Continuous Glucose Monitoring Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 13: Global Continuous Glucose Monitoring Market by Geography 2013-2018
  • Exhibit 14: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 15: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 16: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 17: Global Continuous Glucose Monitoring Market: Product Segmentation by Revenue 2013
  • Exhibit 18: Global Continuous Glucose Monitoring Market: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 19: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 20: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 21: Medtronic: Geographical Segmentation by Revenue 2013
Back to Top